Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 Subtype B pol and gagpol DNA Vaccines

J zur Megede, GR Otten, B Doe, H Liu, L Leung… - Journal of …, 2003 - Am Soc Microbiol
Control of the worldwide AIDS pandemic may require not only preventive but also
therapeutic immunization strategies. To meet this challenge, the next generation of human …

Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines

J zur Megede, GR Otten, B Doe, H Liu… - Journal of …, 2003 - pubmed.ncbi.nlm.nih.gov
Control of the worldwide AIDS pandemic may require not only preventive but also
therapeutic immunization strategies. To meet this challenge, the next generation of human …

[HTML][HTML] Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 Subtype B pol and gagpol DNA Vaccines

J zur Megede, GR Otten, B Doe, H Liu, L Leung… - Journal of …, 2003 - ncbi.nlm.nih.gov
Control of the worldwide AIDS pandemic may require not only preventive but also
therapeutic immunization strategies. To meet this challenge, the next generation of human …

[PDF][PDF] Expression and Immunogenicity of

B Subtype, SM Human - Citeseer
Control of the worldwide AIDS pandemic may require not only preventive but also
therapeutic immunization strategies. To meet this challenge, the next generation of human …

Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines.

J zur Megede, GR Otten, B Doe, H Liu, L Leung… - Journal of …, 2003 - europepmc.org
Control of the worldwide AIDS pandemic may require not only preventive but also
therapeutic immunization strategies. To meet this challenge, the next generation of human …

[引用][C] Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines

J ZUR MEGEDE, GR OTTEN… - Journal of …, 2003 - American Society for Microbiology